News

Filter
46 found

MMV launches new P. vivax malaria information hub

26 Jun 2019

Access to Medicines Index highlights role of collaboration in stimulating R&D

21 Nov 2018

Fosun Pharma’s medicine to protect pregnant women from malaria first to be approved by WHO

19 Nov 2018

Single-dose tafenoquine for radical cure of P. vivax malaria submitted for regulatory approval in Brazil

21 Sep 2018

Strides Shasun’s rectal artesunate product receives WHO prequalification

21 Jun 2018

WHO issues information note on correct use of rectal artesunate for severe malaria

18 Dec 2017

Unitaid awards MMV new supply side grant

08 Dec 2017

100 million vials of injectable artesunate distributed since 2010

06 Nov 2017

MMV and Transaid partner to tackle severe malaria in Zambia

31 Oct 2017

MMV and Aga Khan Foundation Canada come together to tackle malaria in Mali

01 May 2017

Cipla’s artesunate suppository first to be quality-assured by Global Fund

16 Dec 2016

MMV partner GSK ranked first in the Access to Medicine Index – again

17 Nov 2016

MMV welcomes WHO approval of 3-year shelf-life for antimalarial ASMQ

08 Mar 2016

Delivery of Coartem® Dispersible reaches a landmark of 300 million treatments

09 Dec 2015
European regulators grant Pyramax® a revised label

European regulators grant Pyramax® a revised label

20 Nov 2015

Eurartesim® (dihydroartemisinin-piperaquine) receives WHO prequalification

26 Oct 2015
Dr David Reddy, CEO, MMV and Dr Bernard Pécoul, CEO, DNDi

DNDi passes the ball to MMV

22 May 2015

MMV joins the Asia Pacific Malaria Elimination Network (APMEN)

23 Apr 2015

MMV recognizes outstanding achievements of ISMO partners

09 Apr 2015

Child-friendly antimalarial reaches new landmark of 250 million treatments delivered

19 Nov 2014

300,000 vials of injectable artesunate delivered to Kenya and Nigeria

04 Nov 2014

Guilin’s SP+AQ added to WHO’s “List of Prequalified Products”

29 Oct 2014

Pyramax now registered in Cambodia

15 Oct 2014

MMV launches the Seasonal Malaria Chemoprevention Tool Kit

29 Apr 2014

Eurartesim® begins ‘real-life’ post African registration safety and effectiveness testing

03 Oct 2013

WHO approves injectable artesunate 30mg & 120mg

24 May 2013

MMV and WHO launch new malaria map tool

25 Apr 2013

Eurartesim® (dihydroartemisinin-piperaquine) registered in first African country

07 Mar 2013

New pack for Injectable Artesunate (InjAS) accepted by WHO Prequalification

25 Feb 2013

MMV and partners handover SMS for Life in Tanzania to Government

07 Jan 2013

MMV to advance WHO-TDR’s pioneering studies on intrarectal artesunate

14 Dec 2012

UNITAID awards MMV-led consortium up to US$ 34 million

11 Dec 2012

Eurartesim® reaches Cambodia

19 Jul 2012

Scaling-up access to life-saving antimalarials in Nigeria

11 Jul 2012

Pyronaridine/artesunate included in the list of WHO prequalified medicines

15 May 2012

SMS for Life wins WSJ Innovation Award 2011

31 Oct 2011

Launch of the CAPSS Plus Pilot in Uganda

30 Sep 2011

MMV signs MoU with ALMA at the African Union Summit

03 Feb 2011

Malawi – determined to control malaria

14 Jul 2010

Ambrose Talisuna: Advocating for access

23 Apr 2010

MMV at ASTMH 2009

11 Nov 2009

MMV supports the need for subsidized antimalarials

12 Oct 2009

Price of Coartem® reduced for the third time in 8 years

13 Aug 2009

UNITAID supports new fund aimed at artemisinin extractors

19 May 2009

MMV applauds GFATM’s decision to host AMFm

11 Nov 2008

MMV welcomes the drop in price of life-saving Coartem®

23 Apr 2008